Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Chaoyin
Contact Chaoyin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Highly Active cis -Diphosphinoalkenyl-Nickel Catalysts for Suzuki–Miyaura Cross-Coupling Reaction of Aryl Chlorides and Aryl Boronic Acids Click to copy article link Article link copied!
Cite Jump to ExpandCollapse ArticleJune 22, 2026 Highly Active cis-Diphosphinoalkenyl-Nickel Catalysts for Suzuki–Miyaura Cross-Coupling Reaction of Aryl Chlorides and Aryl Boronic Acids Click to copy article linkArticle link copied! Xiaoli Li Xiaoli Li College of Chemistry and Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, P. R. China Mengyang Wang Mengyang Wang College of Chemistry and Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, P. R.
Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Immunogenicity of Tetravalent Protein Vaccine, SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: a Phase 2 Trial
Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 13 December 2023 / Approved: 13 December 2023 / Online: 15 December 2023 (01:43:16 CET) Tang, J.; Xu, Q.; Zhu, C.; Xuan, K.; Li, T.; Li, Q.; Pang, X.; Zha, Z.; Li, J.; Qiao, L.; Xu, H.; Wu, G.; Tian, Y.; Han, J.; Gao, C.; Qian, G.; Tian, X.; Xie, L. Immunogenicity of Tetravalent Protein Vaccine, SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: a Phase 2 Trial. Preprints 2023, 2023121078.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Chaoyin
Contact Chaoyin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack